medigraphic.com
Instituto Nacional de Salud Pública

2003, Number S5

<< Back Next >>

salud publica mex 2003; 45 (S5)

Risk factors and reproductive sequelae associated with Chlamydia trachomatis infection in infertile women

Guerra-Infante F, Flores-Medina S, Arteaga-Troncoso G, Zamora-Ruiz A, López-Hurtado M, Javier Ortiz-Ibarra F

Language: Spanish
References: 37
Page: 672-680
PDF size: 103.36 Kb.


ABSTRACT

Objective. To assess the clinical and sexual lifestyle characteristics associated with Chlamydia trachomatis infection among women diagnosed with infertility. Material and Methods. Study subjects were women with an infertility diagnosis attending the infertility clinic at the National Institute of Perinatology. Endocervical specimens from 309 women were examined for Chlamydia trachomatis using the direct immunofluorescence method. Vaginal culture samples were taken before initiating treatment. The presence of other sexually-transmitted infections was also assessed. Demographic, sexual behavioral, historical, and clinical data were collected for each subject. Results. Seventy-seven women (24.9%) were infected with C trachomatis. Of these women, 70 (90.9%) had only one sexual partner, 58 (75.3%) were married, and 19 (24.7%) were single or had a common-law sex partner. Intrauterine device (IUD) was the main contraceptive method used in 15 women (19.5%). A coinfection with other sexually-transmitted microorganisms was detected in 41 of these patients (53.2%). Nineteen (24.7%) women had undergone tubal ligation. Among women with C trachomatis infection, reproductive sequelae were found: 24 (31.2%) women had had abortions and 50 (64.9%) had had a miscarriage. In 26 women cervical abnormalities were detected (33.8%); 50 (64.9%) had purulent vaginal discharge and 14 (18.1%) had pelvic pain. Bivariate analysis revealed that the risk factors for C trachomatis infection in women with infertility were: having a sex partner (OR=2.96, 95% CI 1.22-7.5, p=0.008), common-law union (OR=3.68, p=0.03), and IUD use (OR=2.42, p=0.01). Conclusions. A consistent relationship between C trachomatis infection and infertility was found. Infection with C trachomatis in women with infertility was associated with having one single sexual partner, marital status, and IUD use. The presence of ectropion and friability of the cervix may signal C trachomatis infection. Identification and presumptive therapy should be evaluated as measures to prevent and control C trachomatis infection in patients at risk.


REFERENCES

  1. Cates W, Wasserheit J. Genital chlamydial infections: Epidemiology and reproductive sequelae. Am J Obstet Gynecol 1991;164:1771-1781.

  2. Stamm WE. Chlamydia trachomatis infections: Progress and problems. J Infect Dis 1999;179(2 Suppl):380-383.

  3. Faro S. Chlamydia trachomatis: Female pelvic infection. Am J Obstet Gynecol 1999;164:1767-1770.

  4. Sieper J, Kingsley G. Recent advances in the pathogenesis of reactive arthritis. Immunol Today 1996;17:160-162.

  5. Chernesky M, Luinstra K, Sellors J, Schachter J, Moncada J, Caul O et al. Can serology diagnose upper genital tract Chlamydia trachomatis infection? Sex Trans Dis 1998;25:14-19.

  6. Land JA, Evers JLH, Goossens J. How to use Chlamydia antibody testing in subfertility patients. Hum Reprod 1998;13:1094-1098.

  7. Scholes D, Stergachis A, Ichikawa LE, Heidrich FE, Holmes KK, Stamm WE. Vaginal douching as a risk factor for cervical Chlamydia trachomatis infection. Obstet Gynecol 1998;91:993-997.

  8. Handsfield H, Jasman L, Roberts P. Criteria for selective screening for Chlamydia trachomatis infections in women attending family planning clinics. J Am Med Assoc 1986;255:1730-1734.

  9. Brunham R, Cheang M. Chlamydia trachomatis infertility and population growth in sub Saharan Africa. Sex Transm Dis 1992;20:168-173.

  10. Plummer F, Ngugi R. Prostitutes and their clients in the epidemiology and control of sexually transmitted disease. En: Holmes KK, Mårdh P, Sparling P, Weinser PE, Ed. Sexually transmitted disease. Nueva York (NY): McGraw Hill, 1990:71-76.

  11. Bustos-López HH, Vázquez-Juárez ME, Arredondo-García JL, Lira-Placencia J, Beltrán-Zúñiga M, Guerra-Infante F. Prevalencia de Chlamydia trachomatis en pacientes con esterilidad y embarazos no complicados. Perinatol Reprod Hum 1995;9:227-234.

  12. Ibarra-Camacho A, Sosa-Ceja R, Lugo-de la Fuente G. Frecuencia de Chlamydia trachomatis en mujeres estériles. An Esc Nac Cienc Biol Mex 1991;35:153-159.

  13. Narcio RML, Arredondo GJL, Zaldívar NA, Quesnel GBC, Casanova RG, Guerra IF et al. Etiología microbiana de la enfermedad inflamatoria pélvica leve y moderada (EIP). Ginecol Obstet Mex 1998;66:309-315.

  14. Hernández-Méndez JT, Alonzo-Rojo H, Escamilla-Avilés E, Aquino-Santiago C, Deleón-Rodríguez I, Jiménez-Escalante Z et al. Microorganismos asociados con Chlamydia trachomatis aislados de pacientes con leucorrea. An Esc Nac Cien Biol Mex 2000;46:53-61.

  15. Guerra-Infante FM, Flores-Medina S, López-Hurtado M, Sosa-González IE, Arredondo-García JL. Evaluación de la sensibilidad y especificidad de tres reactivos de inmunofluorescencia directa para el diagnóstico de Chlamydia trachomatis. Ginecol Obstet Mex 1995;63: 368-373.

  16. Hill CS. Molecular diagnostic testing for infectious diseases using TMA technology. Expert Rev Mol Diagn 2001;1:445-455.

  17. Joyner JL, Douglas JM, Foster M, Judson FN. Persistence of Chlamydia trachomatis infection detected by polymerase chain in untreated patients. Sex Transm Dis 2002;29:196-200.

  18. Lan J, Melgers I, Meijer CJ, Walboomers JM, Roosendaal R, Burger C et al. Prevalence and serovar distribution of asymptomatic cervical Chlamydia trachomatis as determinate by highly sensitive PCR. J Clin Microbiol 1995;33:3194-3197.

  19. Luo M, Zhang L, Xiao Y. The prevalence of Chlamydia trachomatis and ureaplasma urealyticum cervical infection in infertility women and the observation of therapeutic efficacy. Human Yi Ke Da Xue Xue Bao 1998; 23:44-46.

  20. Sobocinski Z, Szymanski W, Adamczak R, Ludwikowski G, Przeperki M, Gruzka M. Evaluation of incidence of Chlamydia trachomatis infections among the group of infertile women diagnosed by laparoscopy, and based on properties of Chlamydia trachomatis in the cervical canal, peritoneal fluid and ovarian cyst puncture. Ginekol Pol 2001;72: 224-227.

  21. French JI, McGregor JA, Draper D, Parker R, McFee J. Gestational bleeding, bacterial vaginosis, and common reproductive tract infections: Risk for preterm birth and benefit of treatment. Obstet Gynecol 1999; 93:715-724.

  22. Dowe G, Smikle M, King SD, Wynter H, Frederick J, Hylton-Kong T. High prevalence of genital Chlamydia trachomatis infection in women presenting in different clinical setting in Jamaica: Implications for control strategies. Sex Transm Infect 1999;75:412-416.

  23. Dowe G, King SD. Genital Chlamydia trachomatis (serotypes D-K) infections in Jamaican commercial street sex workers. Genitourin Med 1997; 73:362-364.

  24. Paavonen J, Eggert-Kruse W. Chlamydia trachomatis: Impact on human reproduction. Hum Reprod Update 1999;5:433-447.

  25. Kacmar J, Cheh E, Montagno A, Peipert JF. A randomised trial of azithromycin versus amoxicillin for the treatment of Chlamydia trachomatis in pregnancy. Infect Dis Obstet Gynecol 2001;9:197-202.

  26. Ross JD. An update of pelvic inflammatory disease. Sex Transm Infect 2002;78:18-19.

  27. Stergachis A, Scholes D, Heidrich FE, Sherer DM, Holmes KK, Stamm WE. Selective screening for Chlamydia trachomatis infection in a primary care population of woman. Am J Epidemiol 1993;38:143-153.

  28. Behets FM, Williams Y, Braithwaite A, Hylton-Kong T, Hoffman IF, Dallabetta G et al. Management of vaginal discharge in women treated at a Jamaican sexually transmitted disease clinic: Use of diagnostic algorithms versus laboratory testing. Clin Infect Dis 1995;21:1450-1455.

  29. Pearlman MD, McNeeley SG. A review of the microbiology immunology and clinical implication of Chlamydia trachomatis infections. Obstet Gynecol 1992;7:448-461.

  30. Hernández-Girón C, Cruz-Valdez A, Quitero-Trenado M, Peruga A, Hernández-Avila M et al. Características de comportamiento sexual en hombres de la Ciudad de México. Salud Publica Mex 1999;41:95-100.

  31. Hart G. Risk profiles and epidemiologic interrelationships of sexually transmitted disease. Sex Transm Dis 1993;20:126-136.

  32. Wolner-Hanssen P, Eschenbach DA, Paavonen J, Kiviat N, Stevens CE, Critchloww C et al. Decreased risk of symptomatic chlamydial pelvic inflammatory disease associated with oral contraceptive use. JAMA 1990; 263:54-59.

  33. Guerra-Infante FM, López-Hurtado M. Mecanismos inespecíficos en la eliminación de Chlamydia trachomatis. I. Aspectos microbiológicos y fagocitosis. Perinatol Reprod Hum 1999;13:205-213.

  34. Shafer MA. Enfermedades de transmisión sexual en adolescentes. En: Hansfiel HH, ed. Enfermedad inflamatoria pélvica. Epidemiología, etiología, tratamiento, complicaciones. Nueva York (NY): Practice Publishing Co, 1990; Suplemento del Hospital:8-12.

  35. Centers for Disease Control. Pelvic inflammatory disease: Guidelines for prevention and management. MMWR Morb Mortal Wkly Rep 1991; 40:1-25.

  36. Addiss DG, Vaughn ML, Golubjatnikov R, Pfister J, Kurtycz DF, Davis JP. Chlamydia trachomatis infections in women attending urban midwestern family planning and community health clinics: Risk factors, selective screening and evaluation of non-culture techniques. Sex Transm Dis 1990;17: 138-144.

  37. Moulder JW. Interaction of Chlamydia and host cells in vitro. Microbiol Rev 1991;55:143-190.




2020     |     www.medigraphic.com